Tharimmune Inc. (THAR)

Official site

BIOTECHNOLOGY

$2.02

-0.09 (-4.27%)

Last updated: Oct 13, 2026 at 5:00 PM ET

Earnings

Performance (10Y)

Beat Rate

25%(1/4)

Avg Surprise

-1210.03%

Streak

1 Q

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Sep 30, 2025Sep 25 Reported Nov 12, 2025Reported Nov 12	$-0.34	N/A	-	N/A	Beat	-	-	+86.1%
Jun 30, 2025Jun 25 Reported Aug 14, 2025Reported Aug 14	$-0.64	$0.00	-	N/A	Miss	-	-	+73.5%
Mar 31, 2025Mar 25 Reported May 12, 2025Reported May 12	$-0.99	N/A	-	N/A	Beat	-	-	+65.6%
Dec 31, 2024Dec 24 Reported Mar 26, 2025Reported Mar 26	$-2.14	N/A	-	N/A	Beat	0	No revisions (30d)	-201.4%
Sep 30, 2024Sep 24 Reported Nov 27, 2024Reported Nov 27	$-2.45	N/A	-	N/A	Beat	-	-	-2130.2%
Jun 30, 2024Jun 24 Reported Aug 28, 2024Reported Aug 28	$-2.42	$0.00	$0.00 - $0.00	N/A	Beat	0	No revisions (30d)	+39.6%
Mar 31, 2024Mar 24 Reported May 9, 2024Reported May 9	$-2.88	$0.00	$0.00 - $0.00	N/A	Beat	0	No revisions (30d)	+49.9%
Dec 31, 2023Dec 23 Reported Feb 23, 2024Reported Feb 23	$-0.71	$-1.25	-	+43.20%	Beat	1	1 0 30d	-373.3%
Sep 30, 2023Sep 23 Reported Nov 7, 2023Reported Nov 7	$-0.11	$-0.06	$-0.06 - $-0.06	-83.33%	Miss	1	No revisions (30d)	+38.9%
Jun 30, 2023Jun 23 Reported Aug 30, 2023Reported Aug 30	$-4.00	$-0.16	-	-2400.00%	Miss	-	-	-2757.1%
Mar 31, 2023Mar 23 Reported May 31, 2023Reported May 31	$-5.75	$-0.23	-	-2400.00%	Miss	-	-	-2513.6%
Dec 31, 2022Dec 22 Reported Mar 16, 2023Reported Mar 16	$-0.15	N/A	-	N/A	Beat	-	-	-87.5%
Sep 30, 2022Sep 22 Reported Nov 14, 2022Reported Nov 14	$-0.18	N/A	-	N/A	Beat	-	-	+25.0%
Jun 30, 2022Jun 22 Reported Aug 11, 2022Reported Aug 11	$-0.14	N/A	-	N/A	Beat	-	-	-
Mar 31, 2022Mar 22 Reported May 16, 2022Reported May 16	$-0.22	N/A	-	N/A	Beat	-	-	-
Dec 31, 2021Dec 21 Reported Jan 13, 2022Reported Jan 13	$-0.08	$0.00	-	N/A	Miss	-	-	-
Jun 30, 2021Jun 21 Reported Sep 27, 2021Reported Sep 27	$-0.24	$0.00	-	N/A	Miss	-	-	-

Key Metrics

Valuation
P/E Ratio	N/A	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	N/A	Operating Margin	N/A
ROE	N/A	ROIC	-163.67%
Financial Health
Debt/Equity	0.03x	Interest Coverage	-412.87x
Current Ratio	4.98x	Quick Ratio	4.98x
Trading Statistics
Beta	N/A	Avg Volume	917.19K
52-Week High	N/A	52-Week Low	N/A

Technical Indicators Dashboard

Moving Averages

SMA 10$2.21

SMA 20$2.28

SMA 50$2.17

SMA 200$3.04

EMA 10$2.18

EMA 20$2.22

EMA 50$2.26

EMA 200$2.64

MACD

Line: -0.03Signal: 0.01Hist: -0.04

ADX

ADX: 15.9+DI: 19.6-DI: 24.5

Aroon & PSAR

Aroon Up56.0

Aroon Down24.0

PSAR$2.61

Bollinger Bands

Upper Band$2.63

Lower Band$1.92

%B Position3120%(Upper)

Band Width0.14

RSI (14-Day)

Neutral

41.1

Momentum Oscillators

Stoch %K6.5

Stoch %D7.9

Williams %R-96.9

ROC (10d)-15.1%

Momentum-0.36

CCI (20d)-119.7

MFI (14d)52.4

Volatility Measures

ATR (14d)$0.17(8.4%)

StdDev (20d)0.18

Hist Vol95.1%(High)

Volume Flow

VWAP$2.05

OBV575.5M

AD Line156.1M

CMF (20d)-0.070

Volume Metrics

Avg Vol (20d)953.6K

Vol Ratio1.1x

VWMA (20d)$2.29

Pivot Points

R3$2.19

R2$2.16

R1$2.14

Pivot Point$2.11

S1$2.08

S2$2.05

S3$2.03

Advanced Oscillators

TSI-4.10

Ultimate Osc37.2

KST33.56

Financial Data

Quarter	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022
Total Revenue	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Operating Expenses	$2.09M	$1.85M	$2.55M	$3.85M	$3.87M	$2.37M	$2.35M	$2.53M	$1.85M	$2.36M	$2.71M	$1.77M
R&D	$277,803	$546,204	$594,070	$2.09M	$2.28M	$999,553	$1.03M	$992,725	$488,177	$1.03M	$1.05M	$683,205
SG&A	$1.82M	$1.30M	$1.95M	$1.76M	$1.58M	$1.37M	$1.32M	$1.54M	$1.36M	$1.33M	$1.67M	$1.08M
Operating Income	$-2,093,578	$-1,851,160	$-2,546,669	$-3,847,464	$-3,865,571	$-2,373,454	$-2,347,303	$-2,531,156	$-1,845,070	$-2,364,596	$-2,714,398	$-1,766,438

Interest Income	$1,388	$2,168	$13,436	$27,672	$72,728	$53,614	$95,894	$57,733	$28,451	$34,199	$32,248	$0
Interest Expense	$9,648	$6,161	$8,471	$758	$3,009	$5,217	$4,700	$354	$3,496	$6,517	$6,138	$0
Income Before Tax	$-2,101,838	$-1,855,153	$-2,541,704	$-3,820,550	$-3,795,852	$-2,325,057	$-2,256,109	$-2,473,777	$-1,820,115	$-2,336,914	$-2,688,288	$-1,766,438
Income Tax Expense	$0	$0	$0	$43,276	$0	$0	$-43,276	$13,921	$68,037	$-87,886	$-9,336	$-54,880

Net Income	$-2,101,838	$-1,855,153	$-2,541,704	$-3,820,550	$-3,795,852	$-2,325,057	$-2,256,109	$-2,473,777	$-1,820,115	$-2,336,914	$-2,688,288	$-1,766,438

EBITDA	$-2,092,190	$-1,848,992	$-2,533,233	$-3,819,792	$-3,792,843	$-2,319,840	$-2,251,409	$-2,429,611	$-1,816,619	$-2,208,312	$-2,640,566	$-1,766,438
EBIT	$-2,092,190	$-1,851,160	$-2,546,669	$-3,847,464	$-3,865,571	$-2,373,450	$-2,251,409	$-2,473,423	$-1,777,033	$-2,330,397	$-2,682,150	$-1,766,438

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about THAR

News

No news available

Company news will appear here when available

THAR Valuation and Fair Value

P/B: 2.0x

See GNG's fair value

THAR Profitability: Margins, ROIC and FCF

ROIC: -163.7%

THAR Competitors

Company	Ticker
Synlogic Inc	SYBX
Pluri Inc.	PLUR
Anebulo Pharmaceuticals Inc	ANEB
In8bio Inc	INAB
GT Biopharma Inc	GTBP
Passage Bio Inc	PASG
Femasys Inc	FEMY
Intensity Therapeutics, Inc. Common stock	INTS

Sector: Healthcare

THAR Bull Case vs Bear Case

Bear case

THAR beat EPS estimates in 12.5% of its last 8 reported quarters.

THAR Earnings: Beat Rate and Next Report

Beat rate: 1 of 8 quarters (12.5%)
Average surprise: -1210.0%

Frequently Asked Questions About THAR

Does THAR pay dividends?

Tharimmune Inc. (THAR) does not currently pay a regular dividend.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In